Westwood Holdings Group Inc. Increases Stake in Teleflex Incorporated $TFX

Westwood Holdings Group Inc. lifted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 10.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 121,534 shares of the medical technology company’s stock after purchasing an additional 11,261 shares during the period. Westwood Holdings Group Inc. owned about 0.28% of Teleflex worth $14,385,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the business. T. Rowe Price Investment Management Inc. grew its stake in shares of Teleflex by 0.7% during the first quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company’s stock valued at $859,095,000 after buying an additional 43,642 shares during the last quarter. Cooke & Bieler LP boosted its holdings in Teleflex by 14.0% during the 2nd quarter. Cooke & Bieler LP now owns 1,205,964 shares of the medical technology company’s stock valued at $142,738,000 after acquiring an additional 148,436 shares during the period. Dimensional Fund Advisors LP grew its position in Teleflex by 69.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company’s stock worth $119,927,000 after acquiring an additional 355,720 shares during the last quarter. Qube Research & Technologies Ltd increased its stake in Teleflex by 100.1% in the 2nd quarter. Qube Research & Technologies Ltd now owns 606,804 shares of the medical technology company’s stock worth $71,821,000 after purchasing an additional 303,521 shares during the period. Finally, Norges Bank bought a new stake in Teleflex in the second quarter valued at approximately $65,826,000. 95.62% of the stock is owned by institutional investors.

Teleflex Trading Down 0.4%

NYSE:TFX opened at $126.69 on Monday. The company has a 50-day moving average price of $120.22 and a 200-day moving average price of $120.92. The stock has a market cap of $5.60 billion, a price-to-earnings ratio of -17.24, a P/E/G ratio of 1.51 and a beta of 0.95. The company has a current ratio of 2.57, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. Teleflex Incorporated has a 12 month low of $102.58 and a 12 month high of $185.94.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The company had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. During the same quarter in the previous year, the company earned $3.49 earnings per share. Teleflex’s quarterly revenue was up 19.4% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Equities analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Friday, November 14th will be given a $0.34 dividend. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. Teleflex’s dividend payout ratio is currently -18.50%.

Analyst Ratings Changes

A number of research firms have recently weighed in on TFX. Truist Financial dropped their price objective on Teleflex from $128.00 to $120.00 and set a “hold” rating for the company in a research note on Monday, November 10th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Tuesday, December 9th. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 8th. Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Finally, Wells Fargo & Company raised their target price on Teleflex from $114.00 to $139.00 and gave the stock an “equal weight” rating in a research note on Wednesday. One research analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $138.14.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.